SLC16A2 and Allan-Herndon-Dudley syndrome: Our experiments with TH analogs demonstrated that DITPA and TRIAC could trigger improved responses (induction/repression of T3-responsive genes) in MCT8-deficient human neural cells, highlighting the promising potential for the early use of TH analogs in the treatment of patients with AHDS.